Grossman Roth Yaffa Cohen is currently investigating potential claims from patients who suffered injuries involving defective PowerPort™ catheters manufactured by Bard.
As implantable port catheters that have been linked to dangerous complications, Bard PowerPort devices have become the subject of a growing number of lawsuits filed by victims who suffered injuries caused by device breakage, implant migration, and other complications.
If you or someone you love experienced complications after receiving a Bard PowerPort catheter implant, you may have grounds to pursue legal action and a financial recovery of your damages.
Grossman Roth Yaffa Cohen has decades of experience litigating complex and high-profile claims involving defective products and medical devices. If you have questions about a potential Bard PowerPort lawsuit, we want to help. Call (866) 629-1061 or contact us online for a FREE consultation.
Bard PowerPort Catheters Linked to Dangerous Complications
The Bard PowerPort is a port catheter that is implanted under the skin to provide long-term access to the bloodstream, often for chemotherapy and other similar treatments. The device features an injection port, or reservoir, where needles are inserted, a PowerLoc needle, which allows medications to be injected into the implanted port, and a catheter tube that transports intravenous fluids directly into the blood vessel.
While Bard has marketed its PowerPort as a device that can withstand higher injection pressure and allow for faster and more convenient mediation delivery, the PowerPort has been linked to a growing number of adverse event reports from physicians and patients.
These complaints involve a few serious and life-threatening complications, including:
- Fracturing events, in which small fragments of the catheter break from the device and enter the patient’s vascular system.
- Device migration, which can cause injuries to tissue, organs, and blood vessels.
Fracturing and migration of port catheter devices pose risks for serious and life-threatening injuries. Some of the injuries associated with the Bard PowerPort include:
- Infections and sepsis
- Blood clots, including pulmonary embolism and deep vein thrombosis (DVT)
- Hemorrhaging or bleeding injuries
- Cardiac arrhythmia
- Severe and chronic pain
- Vascular damage
- Tissue and organ perforation
- Patient death
In 2020, Bard issued an FDA-initiated recall for certain PowerPort devices, after the agency advised all healthcare facilities to return affected devices to mitigate patient risks. Unfortunately, the PowerPort has continued to cause patient injuries, giving rise to a growing number of lawsuits.
Lawsuits Claim PowerPort Catheters Were Defectively Designed, Manufactured
Given the large number of adverse event reports, FDA recall, and growing evidence about the dangers of the PowerPort device, patients across the country have begun filing lawsuits against Bard, Becton Dickinson and Co. (which acquired Bard in 2017), and other manufacturers involved in the development and creation of the PowerPort catheter.
These lawsuits raise several claims, including allegations that:
- PowerPort devices were defectively designed and manufactured and were more likely to break or migrate once implanted in patients.
- Bard and manufacturers knew or should have known about the problems associated with the PowerPort but failed to address them.
- Bard and manufacturers failed to adequately warn about risks associated with the PowerPort.
According to the lawsuits, problems with the PowerPort device stem from its use of Chronoflex AL catheter tubes produced by AdvanSource Biomaterials, which contain excessively high concentrations of barium sulfate, a compound that affects the integrity of polyurethane.
The lawsuits claim that higher barium sulfate levels resulted in improper mixing during manufacturing and irregular catheter surfaces that made PowerPort catheter tubes more likely to degrade, crack, fracture, and fissure, increasing the risk of blood clots, infections, and other injuries.
The suits also claim that the catheter and fragments of broken devices were prone to migration to unintended locations in the body, increasing risks of organ vascular injuries.
GRYC is Investigating Potential Claims
As a firm that’s earned national recognition litigating complex products liability claims, Grossman Roth Yaffa Cohen is now investigating potential claims from victims who suffered injuries and losses caused by PowerPort catheters and other Bard catheter devices, including the Powerflow®, SlimPort, and X-Port™.
You may have a potential case if:
- You had a Bard PowerPort implant and experienced injuries caused by device breakage or migration.
- You’re loved one suffered a wrongful death due to complications associated with an implanted Bard PowerPort catheter.
Call For a FREE Consultation: (866) 629-1061
Grossman Roth Yaffa Cohen is a top-rated South Florida trial practice with a national reputation. Backed by award-winning attorneys, we’ve become known for taking on some of the largest and most powerful corporations in the world, and have secured millions in compensation in litigation involving serious personal injury, wrongful death, medical malpractice, and defective products.
If you have questions regarding a potential Bard PowerPort lawsuit, we want to help. Our firm serves victims and families nationwide and offers FREE consultations. Call (866) 629-1061 or contact us online to speak with a lawyer.
